-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $65

Benzinga·02/12/2026 19:01:00
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $62 to $65.